NNVC Stock Analysis

NNVC -  USA Stock  

USD 3.96  0.15  3.94%

The current slip in stock price may encourage investors to take a closer look at the firm as it is trading at a share price of 3.96 on 50,297 in trading volume. The company directors and management have failed to build on market volatilities in May. However, diversifying your overall positions with Nanoviricides may protect your principal portfolio during upcoming market swings. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.72. This high volatility is attributed to the latest market swings and not so good earnings reports for some of the Nanoviricides partners.
Additionally, see Stocks Correlation.

Search Stock Analysis 

 
Refresh
The Nanoviricides stock analysis report makes it easy to digest most publicly released information about Nanoviricides and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. NNVC stock analysis module also helps to analyze the Nanoviricides price relationship with some important fundamental indicators such as market cap and management efficiency.

NNVC Stock Analysis Notes

The company has price-to-book ratio of 1.7. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Nanoviricides recorded a loss per share of 1.63. The entity had not issued any dividends in recent years. The firm had 10:35 split on the 24th of September 2019. NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut. Nanoviricides operates under Biotechnology classification in the United States and is traded on NYSEMKT Exchange. It employs 17 people. To find out more about Nanoviricides contact Irach Taraporewala at 203 937-6137 or learn more at www.nanoviricides.com.

Nanoviricides Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Nanoviricides' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Nanoviricides or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Nanoviricides generates negative expected return over the last 90 days
Nanoviricides has high historical volatility and very poor performance
Nanoviricides has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (14.6 M) with profit before overhead, payroll, taxes, and interest of 0.
Nanoviricides currently holds about 18.39 M in cash with (8.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.72.
Nanoviricides has a frail financial position based on the latest SEC disclosures

Nanoviricides SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Nanoviricides prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Nanoviricides investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Nanoviricides specific information freely available to individual and institutional investors to make a timely investment decision.
16th of February 2021
Unclassified Corporate Event
View
11th of February 2021
Unclassified Corporate Event
View
26th of January 2021
Unclassified Corporate Event
View
4th of January 2021
Unclassified Corporate Event
View
10th of December 2020
Submission of Matters to a Vote of Security Holders
View
19th of November 2020
Financial Statements and Exhibits. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
28th of September 2020
Other Events
View
4th of September 2020
Financial Statements and Exhibits. Regulation FD Disclosure
View

NNVC Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Nanoviricides is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nanoviricides backward and forwards among themselves. Nanoviricides' institutional investor refers to the entity that pools money to purchase Nanoviricides' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Vanguard Group IncCommon Shares278.1 K1.3 M
Blackrock IncCommon Shares226.5 K1.1 M
Bridgeway Capital Management LlcCommon Shares101.4 K479 K
Susquehanna International Group LlpPut Options80.5 K380 K
Geode Capital Management LlcCommon Shares65.3 K308 K
Susquehanna International Group LlpCommon Shares50.9 K240 K
Compagnie Lombard Odier ScmaCommon Shares40 K189 K
Orion Portfolio Solutions LlcCommon Shares30.6 K144 K
Citadel Advisors LlcCall Options20 K94 K
Note, although Nanoviricides' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

NNVC Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 49.35 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Nanoviricides's market, we take the total number of its shares issued and multiply it by Nanoviricides's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

NNVC Profitablity

Nanoviricides' profitability indicators refer to fundamental financial ratios that showcase Nanoviricides' ability to generate income relative to its revenue or operating costs. If, let's say, Nanoviricides is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Nanoviricides' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Nanoviricides' profitability requires more research than a typical breakdown of Nanoviricides' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2021
Return on Average Assets(0.97) (1.05) 
Return on Average Equity(1.17) (1.26) 
Return on Invested Capital(1.84) (1.98) 

Management Efficiency

The entity has return on total asset (ROA) of (16.92) % which means that it has lost $16.92 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (82.32) %, meaning that it created substantial loss on money invested by shareholders. Nanoviricides management efficiency ratios could be used to measure how well nanoviricides manages its routine affairs as well as how well it operates its assets and liabilities. As of June 20, 2021, Return on Average Assets is expected to decline to -1.05. In addition to that, Return on Average Equity is expected to decline to -1.26. Nanoviricides Total Assets are projected to increase significantly based on the last few years of reporting. The past year's Total Assets were at 27.5 Million. The current year Current Assets is expected to grow to about 13.5 M, whereas Assets Non Current are forecasted to decline to about 10.3 M.
Last ReportedProjected for 2021
Book Value per Share 3.49  4.36 
Enterprise Value over EBIT(5.75) (5.90) 
Enterprise Value over EBITDA(5.72) (6.17) 
Price to Book Value 2.81  2.88 
Tangible Assets Book Value per Share 3.77  5.47 
Enterprise Value56.6 M71.6 M
Tangible Asset Value27.1 M27.7 M

Technical Drivers

As of the 20th of June, Nanoviricides secures the mean deviation of 3.22, and Risk Adjusted Performance of (0.037252). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nanoviricides, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Nanoviricides, which can be compared to its peers in the industry. Please verify Nanoviricides treynor ratio, as well as the relationship between the downside variance and kurtosis to decide if Nanoviricides is priced some-what accurately, providing market reflects its recent price of 3.96 per share. Given that Nanoviricides has jensen alpha of (0.34), we recommend you to check Nanoviricides's last-minute market performance to make sure the company can sustain itself at a future point.

Nanoviricides Price Movement Analysis

The output start index for this execution was thirty-two with a total number of output elements of twenty-nine. The MESA Adaptive Moving Average indicator adapts to Nanoviricides price movement based on the rate change of phase as measured by the Hilbert Transform Discriminator. View also all equity analysis or get more info about mesa adaptive moving average overlap studies indicator.

Nanoviricides Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nanoviricides insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nanoviricides' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Nanoviricides insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Nanoviricides Technical and Predictive Indicators

Nanoviricides Forecast Models

Nanoviricides time-series forecasting models is one of many Nanoviricides' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Nanoviricides' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Nanoviricides Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Nanoviricides stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling NNVC shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Nanoviricides. By using and applying NNVC Stock analysis, traders can create a robust methodology for identifying NNVC entry and exit points for their positions.
NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut. Nanoviricides operates under Biotechnology classification in the United States and is traded on NYSEMKT Exchange. It employs 17 people.

Current NNVC Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. NNVC analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. NNVC analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
12.0Strong Buy1Odds
Nanoviricides current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most NNVC analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand NNVC stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Nanoviricides, talking to its executives and customers, or listening to NNVC conference calls.
NNVC Analyst Advice Details

NNVC Stock Analysis Indicators

Nanoviricides stock analysis indicators help investors evaluate how Nanoviricides stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Nanoviricides shares will generate the highest return on investment. By understating and applying Nanoviricides stock analysis, traders can identify Nanoviricides position entry and exit signals to maximize returns.
Quick Ratio54.21
Fifty Two Week Low2.8500
Shares Short Prior Month1.12M
Average Daily Volume Last 10 Day83.11k
Average Daily Volume In Three Month130.65k
Shares Percent Shares Out9.26%
Short Percent Of Float9.81%
Forward Price Earnings-9.80
Float Shares9.55M
Fifty Two Week High9.9700
Enterprise Value To Ebitda-5.09
Fifty Day Average3.7453
Two Hundred Day Average4.1345
Additionally, see Stocks Correlation. Note that the Nanoviricides information on this page should be used as a complementary analysis to other Nanoviricides' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Complementary Tools for Nanoviricides Stock analysis

When running Nanoviricides price analysis, check to measure Nanoviricides' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanoviricides is operating at the current time. Most of Nanoviricides' value examination focuses on studying past and present price action to predict the probability of Nanoviricides' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Nanoviricides' price. Additionally, you may evaluate how the addition of Nanoviricides to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
The market value of Nanoviricides is measured differently than its book value, which is the value of NNVC that is recorded on the company's balance sheet. Investors also form their own opinion of Nanoviricides' value that differs from its market value or its book value, called intrinsic value, which is Nanoviricides' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nanoviricides' market value can be influenced by many factors that don't directly affect Nanoviricides underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nanoviricides' value and its price as these two are different measures arrived at by different means. Investors typically determine Nanoviricides value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nanoviricides' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.